2016

  1. Mercaptopurine in postoperative recurrence CD

  2. Infliximab in postoperative recurrence CD

  3. Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: theMOMENTUM Trial

  4. Allogeneic adipose-derived mesenchymal stem cells (Cx601) in perianal CD

  5. Granulocyte/Monocyte Apheresis in UC

  6. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with CD

  7. Infliximab vs cyclosporine in ASUC